INSPIRE: Neurovascular Product Surveillance Registry

Sponsor
Medtronic Neurovascular Clinical Affairs (Industry)
Overall Status
Recruiting
CT.gov ID
NCT02988128
Collaborator
Medtronic Bakken Research Center (Industry)
3,000
60
119
50
0.4

Study Details

Study Description

Brief Summary

Post market surveillance registry

Condition or Disease Intervention/Treatment Phase
  • Device: Treatment for intracranial aneurysms
  • Device: Treatment for Acute Ischemic Stroke

Detailed Description

An observational, prospective, multi-center, single-arm registry to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic Neurovascular market-released products used in the treatment of Intracranial aneurysms and Acute Ischemic Stroke.

This study is conducted under the Product Surveillance Registry (NCT01524276).

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
3000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
NeuroVascular Product Surveillance Registry (PSR) Platform
Study Start Date :
Dec 1, 2016
Anticipated Primary Completion Date :
Nov 1, 2026
Anticipated Study Completion Date :
Nov 1, 2026

Outcome Measures

Primary Outcome Measures

  1. The clinical success rate defined as complete occlusion of target aneurysm without retreatment or significant artery stenosis (≤ 50%). [1 year]

    For Intracranial Aneurysm the primary outcome is the clinical success rate defined as complete occlusion of target aneurysm without retreatment or significant artery stenosis (≤ 50%).

  2. Functional Independence: mRS score ≤ 2 [90 days]

    For Acute ischemic stroke the primary outcome is functional Independence: modified Rankin Scale (mRS) score ≤ 2

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements

  • Patient has, or is intended to receive or be treated with, an eligible Medtronic product

  • Patient is consented within the enrollment window of the therapy received, as applicable

  • Patient is at least 18 years of age at time of enrollment.

Exclusion Criteria:
  • Patient who is, or is expected to be inaccessible for follow-up

  • Patient with exclusion criteria required by local law

  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

  • Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 ENERI Buenos Aires Argentina
2 Gold Coast University Hospital Southport Australia
3 Ziekenhuis Oost Limburg - Campus Sint-Jan Genk Belgium
4 Universitair Ziekenhuis Gent Gent Belgium
5 Rigshospitalet Copenhagen Denmark
6 Turun Yliopistollinen keskussairaala Turku Finland
7 CHU Besancon - Hôpital Jean Minjoz Besançon France
8 CHU Brest, Hôpital de la Cavale Blanche Brest France
9 Hôpital Pierre Wertheimer Bron France
10 CHU de Caen Caen France
11 AP-HP Hôpital Bicêtre Le Kremlin-Bicêtre France
12 CHU Limoges - Hôpital Dupuytren Limoges France
13 Hôpital de la Timone-CHU de Marseille Marseille France
14 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier France
15 CHU de Nancy - Hôpital Central Nancy France 54035
16 CHU de Nantes Hôpital Laennec Nantes France
17 GHU Paris Psychiatrie & Neurosciences Paris France 75014
18 Fondation Ophtalmologique Adolphe de Rothschild Paris France
19 Hôpital de la Pitié Salpétrière Paris France
20 CHU Reims Hôpital Maison Blanche Reims France
21 CHU Hôpitaux de Rouen - Hôpital Charles Nicolle Rouen France
22 CHU Toulouse - Hôpital Pierre-Paul Riquet Toulouse France
23 Klinikum Augsburg Augsburg Germany
24 Charité Universitätsmedizin Berlin -Campus Charite Berlin Germany
25 HELIOS Klinikum Erfurt Erfurt Germany
26 Universitätsklinikum Erlangen Erlangen Germany
27 Alfried Krupp Krankenhaus Essen Germany
28 Universitätsklinikum Freiburg Freiburg Germany 79065
29 Universitätsklinikum Hamburg-Eppendorf Hamburg Germany
30 Universitätsklinikum Heidelberg Heidelberg Germany
31 Hellenic Airforce 251 General Hospital Athen Greece
32 Prince of Wales Hospital Hong Kong Hong Kong
33 The University of Hong Kong Hong Kong Hong Kong
34 Országos Klinikai Idegtudományi Intézet Budapest Hungary
35 Hadassah Medical Organization Jerusalem Israel
36 Sheba Medical Center Ramat Gan Israel
37 Azienda Ospedaliero-Universitaria Careggi Firenze Italy
38 Azienda Ospedaliera Ospedale Niguarda Cà Granda Milano Italy
39 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Milan Italy 20133
40 Military Medical Institute-Wojskowy Instytut Medyczny Warszawa Poland 04-141
41 Centro Hospitalar de Vila Nova de Gaia/Espinho - Unidade I Vila Nova de Gaia Portugal 4434-502
42 Siberian Federal Biomedical Research Center Novosibirsk Russian Federation
43 Almazov National Medical Research Centre St. Petersburg Russian Federation
44 CINRE s.r.o. Bratislava Slovakia
45 Chris Hani Baragwaneth Hospital Johannesburg South Africa
46 Hospital De Cruces Barakaldo Spain
47 Hospital Vall D'Hebron Barcelona Spain
48 Hospital Fundación Jiménez Díaz Madrid Spain
49 Hospital Universitario de La Paz Madrid Spain
50 Hospital Universitario Central de Asturias Oviedo Spain
51 Hospital Universitario Donostia San Sebastián Spain
52 Hospital Universitario Virgen del Rocío Sevilla Spain 41013
53 Hospital Clínico Universitario de Valladolid Valladolid Spain
54 Hospital Álvaro Cunqueiro Vigo Spain 36312
55 Inselspital - Universitätsspital Bern Bern Switzerland
56 Hôpitaux Universitaires de Genève Geneve Switzerland
57 Cleveland Clinic - Abu Dhabi Abu Dhabi United Arab Emirates
58 University Hospitals of Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham United Kingdom
59 Barking, Havering and Redbridge University Hospitals - Queen's Hospital Romford United Kingdom
60 University Hospitals of North Midlands NHS Trust - Royal Stoke University Hospital Stoke on Trent United Kingdom ST4 6QG

Sponsors and Collaborators

  • Medtronic Neurovascular Clinical Affairs
  • Medtronic Bakken Research Center

Investigators

  • Study Chair: Markus Holtmannspotter, MD, Klinikum Nürnberg Süd
  • Study Chair: Laurent Spelle, MD, Hôpital Bicêtre, Service de Neuroradiologie Interventionnelle Adulte et Pédiatrique
  • Study Chair: Jens Fiehler, MD, Universitätsklinikum Hamburg-Eppendorf
  • Study Chair: István Szikora, MD, National Institute of Clinical Neurosciences
  • Study Chair: Mario Galdamez, MD, Hospital Clínico Universitario de Valladolid
  • Study Chair: Saleh Lamin, MD, Queen Elisabeth Hospital, Neuroradiology
  • Study Chair: Francis Turjman, MD, Hôpital Pierre Wertheimer
  • Study Chair: Christophe Cognard, MD, CHU Toulouse - Hôpital Purpan
  • Study Chair: Markus Möhlenbruch, MD, University Hospital Heidelberg
  • Study Chair: Marc Ribó, MD, Hospital Vall d'Hebron
  • Study Chair: Pasquale Mordasini, MD, Inselspital - Universitätsspital Bern
  • Study Chair: Sanjeev Nayak, MD, University Hospitals of North Midlands NHS Trust - Royal Stoke University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medtronic Neurovascular Clinical Affairs
ClinicalTrials.gov Identifier:
NCT02988128
Other Study ID Numbers:
  • MDT16056/MDT17077
First Posted:
Dec 9, 2016
Last Update Posted:
Jul 22, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Medtronic Neurovascular Clinical Affairs
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2022